Abstract
The purpose of this pictorial essay is to illustrate a spectrum of normal variants and potential pitfalls in integrated positron emission tomography (PET)/computed tomography (CT) imaging in the evaluation of patients with non-small cell lung cancer. Knowledge of the normal variants and potential pitfalls in PET/CT imaging as well as patients' clinical histories, together with the use of CT to localize foci of increased tracer uptake accurately, is useful in preventing misinterpretation.
MeSH terms
-
Adipose Tissue, Brown / pathology
-
Aged
-
Arteriosclerosis / diagnosis
-
Arteriosclerosis / pathology
-
Artifacts
-
Blood Glucose / metabolism
-
Carcinoma, Non-Small-Cell Lung / diagnosis*
-
Carcinoma, Non-Small-Cell Lung / pathology
-
Contrast Media / administration & dosage
-
Contrast Media / pharmacokinetics
-
Diagnosis, Differential
-
Diagnostic Errors
-
Female
-
Fluorodeoxyglucose F18 / pharmacokinetics
-
Humans
-
Iatrogenic Disease
-
Image Processing, Computer-Assisted* / instrumentation*
-
Lung / pathology
-
Lung Neoplasms / diagnosis*
-
Male
-
Middle Aged
-
Muscle, Skeletal / pathology
-
Neoplasm Staging
-
Positron-Emission Tomography / instrumentation*
-
Reference Values
-
Sensitivity and Specificity
-
Tomography, Spiral Computed / instrumentation*
Substances
-
Blood Glucose
-
Contrast Media
-
Fluorodeoxyglucose F18